Does the relaxin, estrogen and matrix metalloproteinase axis contribute to degradation of TMJ fibrocartilage?

Journal of Musculoskeletal Neuronal Interactions

Volumn 3, Issue 4, 2003, Pages 401-405

  Kapila, Sunil ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Collagenase; Fibrocartilage; Relaxin; Stromelysin

Indexed keywords

COLLAGENASE; ESTRADIOL; ESTROGEN; MATRIX METALLOPROTEINASE; RELAXIN; STROMELYSIN; TISSUE INHIBITOR OF METALLOPROTEINASE;

AGE DISTRIBUTION; ARTICLE; BINDING AFFINITY; CARTILAGE CELL; CARTILAGE DEGENERATION; CARTILAGE MATRIX; CELL CULTURE; CELL SPECIFICITY; CELL TYPE; CONNECTIVE TISSUE; EXPLANT; FEMALE; HUMAN; JOINT DEGENERATION; MALE; MODULATION; OSTEOARTHRITIS; PROTEIN EXPRESSION; RHEUMATOID ARTHRITIS; SEX DIFFERENCE; SYNOVIOCYTE; TEMPOROMANDIBULAR JOINT DISORDER;

EID: 1642431870     PISSN: 11087161     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (46)

1. Lipton JA, Ship JA, Larach-Robinson D. Estimated prevalence and distribution of reported orofacial pain in the United States. J Am Dent Assoc 1993; 124:115-121.
2. Von Korff M, Dworkin SF, LeResche L, Kruger A. An epidemiologic comparison of pain complaints. Pain 1988; 32:173-183.
3. Westling L. Temporomandibular joint dysfunction and systemic joint laxity. Swed Dent J Suppl 1992; 81:1-79.
4. McNeil C. Craniomandibular Disorders: Guidelines for Evaluation, Diagnosis and Management. The American Academy of Craniomandibular Disorders. Quintessence Publishing Inc., Chicago; 1993.
5. Dworkin SF, Huggins KH, LeResche L, Von Korff M, Howard J, Truelove E, Sommers E. Epidemiology of signs and symptoms in temporomandibular disorders: clinical signs in cases and controls. J Am Dent Assoc 1990; 1120:273-281.
6. Solberg WK. Epidemiology, incidence and prevalence of temporomandibular disorders: A review. In: The President's Conference on the Examination, Diagnosis and Management of Temporomandibular Disorders. American Dental Association, Chicago; 1982.
7. Carlsson GE, LeResche L. Epidemiology of temporomandibular disorders. In: Sessle BJ, Bryant PS, Dionne RA (eds) Progress in Pain Research and Management: Temporomandibular Disorders and Related Pain Conditions. IASP Press, Seattle; 1995:211-226.
8. Abubaker AO, Raslan WF, Sotereanos GC. Estrogen and progesterone receptors in temporomandibular joint discs of symptomatic and asymptomatic persons: a preliminary study. J Oral Maxillofac Surg 1993; 51:1096-1100.
9. Auldemorte TB, Van Sickels JE, Dolwick MF. Estrogen receptors in the temporomandibular joint of the baboon: an autoradiographic study. Oral Surg Oral Med Oral Pathol 1986; 61:307-314.
10. Campbell JH, Courey MS, Bourne P. Estrogen receptor analysis of human temporomandibular disc. J Oral Maxillofac Surg 1993; 51:1101-1105.
11. Milam SB, Aufdemorte T13, Sheridan PJ. Sexual dimorphism in the distribution of estrogen receptors in the temporomandibular joint complex of baboons. Oral Surg Oral Med Oral Pathol 1987; 64:527-532.
12. Hatch JP, Rugh JD, Sakai S, Saunders MJ. Is use of exogenous estrogen associated with temporomandibular signs and symptoms? J Am Dent Assoc 2001; 132:319-326.
13. LeResche L, Saunders K, Von Korff MR, Barlow W, Dworkin SF. Use of exogenous hormones and risk of temporomandibular disorder pain. Pain 1997; 69:153-160.
14. Samuel CS, Parry LJ, Summers RJ. Physiological or pathological - a role for relaxin in the cardiovascular system? Curr Opin Pharmacol 2003; 3:152-158.
15. Mercado-Simmen RC, Bryant-Greenwood GD, Greenwood FC. Relaxin receptor in the rat endometrium: regulation by estrogen and relaxin. Endocrinology 1982; 110:220-226.
16. Mercado-Simmen RC, Goodwin JE, Ueno MS, Yamamoto SY, Bryant-Greenwood GD. Relaxin receptors in the myometrium and cervix of the pig. Biol Reprod 1982; 26:120-128.
17. Olefsky JM, Saekow M, Kroc RL. Potentiation of insulin binding and insulin action by purified porcine relaxin. Ann NY Acad Sci 1982; 380:200-216.
18. Hernandez ER, Resnick CE, Svoboda ME, Van Wyk JJ, Payne DW, Adashi EY. Somatomedin-C/insulin-like growth factor I as an enhancer of androgen biosynthesis by cultured rat ovarian cells. Endocrinology 1988; 122:1603-1612.
19. MacLennan AH. The role of the hormone relaxin in human reproduction and pelvic girdle relaxation. Scand J Rheumatol 1991; 88(Suppl.):7-15.
20. Sherwood OD. Relaxin. In: Knobil E, Neill JD (eds) The Physiology of Reproduction. Raven Press Ltd., New York; 1994:861-1009.
21. Treager GW, Ivell R, Bathgate RA, Wade FD. Relaxin 2000. Proceedings of the Third International Conference on Relaxin and Related Peptides. Kluwer Academic Publishers, Dordrecht; 2001.
22. Huang C, Li Y, Anderson LL. Stimulation of collagen secretion by relaxin and effect of oestrogen on relaxin binding in uterine cervical cells of pigs. J Reprod Fertil 1993; 98:153-158.
23. Hwang JJ, Making D, Rookie EA. Relaxin modulates human cervical stromal cell activity. J Clin Endocrinol Metab 1996; 81:3379-3384.
24. Mushayandebvu TI, Rajabi MR. Relaxin stimulates interstitial collagenase activity in cultured uterine cervical cells from nonpregnant and pregnant but not immature guinea pigs; estradiol-17 β restores relaxin's effect in immature cervical cells. Biol Reprod 1995; 53:1030-1037.
25. Too CKL, Kong JK, Greenwood FC, Bryant-Greenwood GD. The effect of oestrogen and relaxin on uterine and cervical enzymes: collagenase, proteoglycanase and β-glycuronidase. Acta Endocrinol 1986; 111:394-403.
26. Unemori E, Amento EP. Relaxin modulates the synthesis and secretion of procollagenase and collagen by human dermal fibroblasts. J Biol Chem 1990; 265:10681-10685.
27. Unemori EN, Beck LS, Lee WP, Xu Y, Siegel M, Keller G, Liggitt HD, Bauer EA, Amento EP. Human relaxin decreases collagen accumulation in vivo in two rodent models of fibrosis. J Invest Dermatol 1993; 101:280-285.
28. Kapila S. Biology of TMJ degeneration: the role of matrix-degrading enzymes. In: McNeil C (ed) Science and Practice of Occlusion. Quintessence Publishing Co. Inc, Chicago; 1995:235-258.
29. Birkedal-Hansen H, Moore WGI, Bodden MK, Windsor LJ, Birkedal-Hansen B, DeCarlo A, Engler JA. Matrix metalloproteinases: a review. Crit Rev Oral Biol Med 1993; 4:197-250.
30. Visse R, Nagase H. Matrix metalloproteinases and tissue inhibitors of metalloproteinases: structure, function, and biochemistry. Circ Res 2003; 92:827-839.
31. Kumkumian GK, Lafyatis R, Remmers EF, Case JP, Kim SJ, Wilderm R. Platelet-derived growth factor and IL,1 interactions in rheumatoid arthritis. Regulation of synoviocyte proliferation, prostaglandin E2 production and collagenase transcription. J Immunol 1989; 143:833-837.
32. Unemori EN, Hibbs MS, Amento EP. Constitutive expression of 92-kD gelatinase (type IV collagenase) by rheumatoid synovial fibroblasts and its induction in normal human fibroblasts by inflammatory cytokines. J Clin Invest 1991; 88:1656-1662.
33. Samuel CS, Butkus A, Coghlan JP, Bateman JF. The effect of relaxin on collagen metabolism in the non-pregnant rat pubic symphysis: the influence of estrogen and progesterone in regulating relaxin activity. Endocrinology 1996; 137:3884-3890.
34. Samuel CS, Coghlan JP, Bateman JF. Effects of relaxin, pregnancy and parturition on collagen metabolism in the rat pubic symphysis. Endocrinology 1998; 159:117-125.
35. Kapila S, Xie Y. Targeted induction of collagenase and stromelysin by relaxin in unprimed and β-estradiol-primed diarthrodial joint fibrocartilaginous cells but not in synoviocytes. Lab Invest 1998; 8:925-938.
36. Hall JA, Anthony RV. Influence of ovarian steroids on relaxin-induced distensibility and compositional changes in the porcine cervix. Bio Reprod 1993; 48:1348-1353.
37. Koos RD, Pillai SB. Intersection of the relaxin and estrogen signaling pathways in the uterus. In: Treager GW, Ivell R, Bathgate RA, Wade FD (eds) Relaxin 2000. Proceedings of the Third International Conference on Relaxin and Related Peptides. Kluwer Academic Publishers, Dordrecht; 2001:101-108.
38. Kapila S, Xie Y. The induction of collagenase by relaxin in fibrocartilaginous cells is mediated by the AP-1 and PEA3 promoter sites. J Dent Res 1998; 77(SI):634.
39. Chihal HJ, Epsey LL. Utilization of the relaxed symphysis pubis of guinea pigs for clues to the mechanism of ovulation. Endocrinology 1973; 93:1441-1444.
40. Fosang AJ, Last K, Maciewicz RA. Aggrecan is degraded by matrix metalloproteinases in human arthritis. Evidence that matrix metalloproteinase and aggrecanase activities can be independent. J Clin Invest 1996; 98:2292-2299.
41. Neuhold LA, Killar L, Zhao W, Sung ML, Warner L, Kulik J, Turner J, Wu W, Billinghurst C, Meijers T, Poole AR, Babij P, DeGennaro LJ. Postnatal expression in hyaline cartilage of constitutively active human collagenase-3 (MMP-13) induces osteoarthritis in mice. J Clin Invest 2001; 107:35-44.
42. Reboul P, Pelletier J-P, Tardif G, Cloutier J-M, Martel-Pelletier J. The new collagenase, collagenase-3, is expressed and synthesized by human chondrocytes but not by synoviocytes. A role in osteoarthritis. J Clin Invest 1996; 97:2011-2019.
43. Bell RJ, Eddie LW, Lester AR, Wood EC, Johnston PD, Niall HD. Relaxin in human pregnancy serum measured with an homologous radioimmunoassay. Obstet Gynecol 1987; 69:585-589.
44. Eddie LW, Bell RJ, Lester A, Geier M, Bennet G, Johnston PD, Niall HD. Radioimmunoassay of relaxin in pregnancy with an analogue of human relaxin. Lancet 1986; 1:1344-1346.
45. Stewart DR, Celniker AC, Taylor CA, Cragun JR, Overstreet J, Lasley B. Relaxin in the peri-implantation period. J Clin Endocrinol Metab 1990; 70:1771-1773.
46. Hsu SY, Nakabayashi K, Nishi S, Kumagai J, Kudo M, Sherwood OD, Hsueh AJ. Activation of orphan receptors by the hormone relaxin. Science 2002; 295:671-674.